0000315066-01-500894.txt : 20011112
0000315066-01-500894.hdr.sgml : 20011112
ACCESSION NUMBER: 0000315066-01-500894
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20011105
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: CARDIAC SCIENCE INC
CENTRAL INDEX KEY: 0000876188
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 330465681
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-41851
FILM NUMBER: 1774649
BUSINESS ADDRESS:
STREET 1: 16931 MILLIKAN AVENUE
CITY: IRVINE
STATE: CA
ZIP: 92606
BUSINESS PHONE: 9495870357
MAIL ADDRESS:
STREET 1: 16931 MILLIKAN AVENUE
CITY: IRVINE
STATE: CA
ZIP: 92606
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: FMR CORP
CENTRAL INDEX KEY: 0000315066
STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000]
IRS NUMBER: 161144965
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: 82 DEVONSHIRE ST
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 6175706339
MAIL ADDRESS:
STREET 1: 82 DEVONSHIRE STREET
CITY: BOSTON
STATE: MA
ZIP: 02109
SC 13G
1
bernie.txt
SC 13G(PIG)
SCHEDULE 13G
Cardiac Science, Inc.
Common Stock
Cusip #141410209
Cusip #141410209
Item 1: Reporting Person - FMR Corp.
Item 4: Commonwealth of Massachusetts
Item 5: 3,327,304
Item 6: 0
Item 7: 3,327,304
Item 8: 0
Item 9: 3,327,304
Item 11: 6.566%
Item 12: HC
Cusip #141410209
Item 1: Reporting Person - Edward C. Johnson 3d
Item 4: United States of America
Item 5: 0
Item 6: 0
Item 7: 3,327,304
Item 8: 0
Item 9: 3,327,304
Item 11: 6.566%
Item 12: IN
Cusip #141410209
Item 1: Reporting Person - Abigail P. Johnson
Item 4: United States of America
Item 5: 0
Item 6: 0
Item 7: 3,327,304
Item 8: 0
Item 9: 3,327,304
Item 11: 6.566%
Item 12: IN
SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(c)
Item 1(a). Name of Issuer:
Cardiac Science, Inc.
Item 1(b). Name of Issuer's Principal Executive Offices:
16931 Millikan Avenue
Irvine, CA 92606
Item 2(a). Name of Person Filing:
FMR Corp.
Item 2(b). Address or Principal Business Office or,
if None,
Residence:
82 Devonshire Street, Boston,
Massachusetts 02109
Item 2(c). Citizenship:
Not applicable
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
141410209
Item 3. This statement is filed pursuant to Rule 13d-1(c)
Item 4. Ownership
(a) Amount Beneficially Owned: 3,327,304
(b) Percent of Class: 6.566%
(c) Number of shares as to which
such person has:
(i) sole power to vote or to direct
the vote: 3,327,304
(ii) shared power to vote or to
direct the vote: 0
(iii) sole power to dispose or to
direct the disposition of: 3,327,304
(iv) shared power to dispose or to direct
the disposition of: 0
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf
of Another Person.
Various persons have the right to receive or the power
to direct the receipt of dividends from, or the proceeds from
the sale of, the Common Stock of Cardiac Science, Inc..
No one person's interest in the common stock of Cardiac Science,
Inc is more than five percent of the
total outstanding common stock
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the Parent
Holding Company.
See attached Exhibit(s) A, B.
Item 8. Identification and Classification of
Members of the Group.
Not Applicable. See attached Exhibit A.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
By signing below I certify that, to the best
of my knowledge and belief, the securities referred
to above were acquired in the ordinary course of business
and were not acquired for the purpose of and do not have
the effect of changing or influencing the control of the
issuer of such securities and were not acquired in connection
with or as a participant in any transaction having
such purpose or effect.
Signature
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the
information set forth in this Schedule 13G in
connection with FMR Corp.'s beneficial ownership
of the Common Stock of Cardiac Science, Inc.
at November 2, 2001 is true, complete and correct.
November 2, 2001
Date
/s/Eric D. Roiter
Signature
Eric D. Roiter
Duly authorized under Power of Attorney
dated December 30, 1997 by and on behalf
of FMR Corp. and its direct and indirect
subsidiaries
SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(c)
FTT Ventures, Limited, 82 Devonshire Street,
Boston, Massachusetts 02109, a Massachusetts
corporation and a wholly-owned subsidiary of
FMR Corp., is the beneficial owner of 1,663,652
shares or 3.283% of the outstanding common
stock of Cardiac Science, Inc. (the "Company").
Included within this figure are 83,183 shares
held in escrow pursuant to an
agreement entered into in connection
with the merger between
the Company and Survivalink Corp.
on October 29, 2001. FTT
Ventures disclaims beneficial
ownership of such shares until
they are released from escrow.
Fidelity Investors Limited Partnership
("FILP"), 82 Devonshire Street, Boston, Massachusetts
02109, a Delaware limited partnership, is the beneficial
owner of 1,297,673 shares or 2.561% of the outstanding
common stock of the Company. Fidelity Investors
Management, LLC ("FIML"), a Delaware limited
liability company, is the general partner and
investment manager of FILP, and is an investment
manager registered under Section
203 of the Investment Advisers Act of 1940.
The members of FIML and the limited partners
of FILP are certain
shareholders and employees of
FMR Corp. Included within this figure
are 64,884 shares held in escrow
pursuant to an agreement entered into in
connection with the merger between Cardiac Science,
Inc. and Survivalink Corp. on October 29, 2001.
FILP disclaims beneficial ownership of
such shares until they are
released from escrow.
Fidelity Investors II Limited Partnership
("FILP II"), 82 Devonshire Street, Boston,
Massachusetts 02109, a Delaware limited
partnership, is the beneficial
owner of 365,979 shares or 0.722% of
the outstanding common stock of the Company.
FIML, is the general partner and investment manager
of FILP II. Included within this figure
are 18,299 shares held in escrow pursuant to
an agreement entered into in connection
with the merger between
Cardiac Science, Inc. and Survivalink Corp.
on October 29, 2001. FILP II disclaims
beneficial ownership of such shares until they
are released from escrow.
Members of the Edward C. Johnson 3d family are
the predominant owners of Class B shares of common stock
of FMR Corp., representing
approximately 49% of the voting power of FMR Corp.
Mr. Johnson 3d owns 12.0% and Abigail Johnson owns
24.5% of the aggregate outstanding voting stock of
FMR Corp. Mr. Johnson 3d is Chairman of FMR Corp.
and Abigail P. Johnson is a Director of FMR Corp.
The Johnson family group and
all other Class B shareholders have entered into a
shareholders' voting agreement under which all
Class B shares will be voted in accordance with the
majority vote of Class B shares. Accordingly, through
their ownership of voting common stock
and the execution of the shareholders' voting agreement,
members of the Johnson family may be deemed, under the
Investment Company Act of 1940, to
form a controlling group with respect to FMR Corp.
SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(c)
RULE 13d-1(f)(1) AGREEMENT
The undersigned persons, on November 2, 2001,
agree and consent to the joint filing on
their behalf of this Schedule 13G in connection
with their beneficial ownership
of the Common Stock of Cardiac Science, Inc.
at November 2, 2001.
FMR Corp.
By /s/Eric D. Roiter
Eric D. Roiter
Duly authorized under Power of Attorney
dated December 30, 1997, by and on behalf
of FMR Corp. and its direct and indirect
subsidiaries
Edward C. Johnson 3d
By /s/Eric D. Roiter
Eric D. Roiter
Duly authorized under Power of Attorney
dated December 30, 1997, by and on behalf
of Edward C. Johnson 3d
Abigail P. Johnson
By /s/Eric D. Roiter
Eric D. Roiter
Duly authorized under Power of Attorney
dated December 30, 1997, by and on behalf
of Abigail P. Johnson